They were also effective against a range of cancer cell lines, with IC50 values below 6 μg/mL, indicating significant apoptotic activity, increased nuclear intensity, plasma membrane permeability, mitochondrial membrane permeability, and cytochrome c release, and outperforming doxorubicin. This evidence concerns the gene CYCS and cancer.